Admaius Capital Partners has formed a strategic partnership with Parkville Holding Company B.V., aiming to expand Parkville's operations in the growing Egyptian healthcare market.
Information on the Target
Parkville Holding Company B.V. is a prominent healthcare and wellness company based in Egypt, renowned for its rapid growth in the cosmeceutical sector. Founded in 2008 by Dr. Samir Ashmawy, with leadership from industry veterans Dr. Sherif Bassiouny and Dr. Mahmoud Farrag, the company has evolved into one of the largest manufacturers in Egypt's consumer healthcare market. Parkville currently offers a diverse portfolio of 125 products, focusing on prescription-based skincare, haircare, food supplements, and muscle relaxants. Its product brands include StarVille, StrongVille, Bobai, Shaan, Enera, Seropipe, Super Kids, and Sulfax, and the company employs over 400 staff members.
Parkville's success can be attributed to its high-quality product offerings and its strong medical marketing team, which consists of 240 sales professionals with established relationships in the medical community. This has enabled Parkville to build a reputation for trust and efficacy in its product line. Additionally, the company operates a state-of-the-art production facility in Alexandria and successfully exports products to six regional markets.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Egypt
The consumer healthcare market in Egypt is characterized by resilient demand growth fueled by increasing consumer awareness and a shift towards locally produced g
Similar Deals
Integrated Diagnostics Holdings → CAIRO RAY for Radiotherapy
2025
CDC Group → Alfa Medical Group
2021
Integrated Diagnostics Holdings PLC → CAIRO RAY for Radiotherapy
Boston Scientific → Nalu Medical
2026
Fawry → Dirac Systems, Virtual CFO, Code Zone
2025
Admaius Capital Partners
invested in
Parkville Holding Company B.V.
in 2024
in a Strategic Partnership deal